Skip to main navigation Skip to search Skip to main content

Hyperprogressive disease during anti-PD-1 (PDCD1) / PD-L1 (CD274) therapy: A systematic review and meta-analysis

  • Jong Yeob Kim
  • , Keum Hwa Lee
  • , Jeonghyun Kang
  • , Edith Borcoman
  • , Esma Saada-Bouzid
  • , Andreas Kronbichler
  • , Sung Hwi Hong
  • , Leandro Fórnias Machado de Rezende
  • , Shuji Ogino
  • , Nana Keum
  • , Mingyang Song
  • , Claudio Luchini
  • , Hans J. van der Vliet
  • , Jae Il Shin
  • , Gabriele Gamerith
  • Yonsei University
  • Institut Curie
  • Université Côte d'Azur
  • Innsbruck Medical University
  • Harvard University
  • Universidade Federal de São Paulo
  • Broad Institute
  • Dana-Farber Harvard Cancer Center
  • Brigham and Women’s Hospital
  • Massachusetts General Hospital
  • University of Verona
  • Vrije Universiteit Amsterdam
  • Tyrolean Cancer Research Institute

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Hyperprogressive disease during anti-PD-1 (PDCD1) / PD-L1 (CD274) therapy: A systematic review and meta-analysis'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology